Nachrichten zur Mesoblast Ltd. (ADRs) Aktie

Why Shares of Mesoblast Are Down Monday

The companys shares continued to tumble after it received a Complete Response Letter last week from the FDA....…

ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively

ADRs End Mostly Higher, Missfresh and Mesoblast Trade Actively...…

Why Shares of Mesoblast Are Plunging Friday

The company received a Complete Response Letter from the FDA regarding its prospective graft-versus-host disease therapy....…

Mesoblast plunges as William Blair downgrades on FDA rejection

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection >MESO

Mesoblast ADSs Plunge Premarket on Latest FDA Rejection >MESO...…

Mesoblast cell therapy for graft versus host disease rejected in U.S.

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast (ASX:MSB) shares plummet on FDA setback

The US Food and Drug Administration (FDA) has rejected Mesoblast’s (MSB) resubmission…...…

UPDATE 1-Mesoblast shares tank after US FDA rejects cell therapy for children

... (Reuters) - The U.S. health regulator rejected Mesoblasts cell therapy......…

Mesoblast shares tank after US FDA delays stem cell approval again

The US regulator has again asked for more data on the stem cell treatment makers flagship product, which was blocked…

Mesoblast Receives Complete Response From U.S. Food and Drug Administration for Biologics License Application for Steroid-Refractory Acute Graft Versus Host Disease in Children

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

XFRA : LWBA: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

XFRA : INSTRUMENT_SUSPENSION - US5907171046

Instrument ID [10157] (LWBA - US5907171046) suspended...…

Form 6-K MESOBLAST LTD For: Aug 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K MESOBLAST LTD For: Jul 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Appendix 4C Quarterly Activity Report for Quarter Ended June 30, 2023

NEW YORK, July 30, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

Are You Looking for a Top Momentum Pick? Why Mesoblast Limited (MESO) is a Great Choice

Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Lets find out....…

Form 6-K MESOBLAST LTD For: Jun 13

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K MESOBLAST LTD For: Jun 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Role

NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

Form 6-K MESOBLAST LTD For: May 26

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 6-K MESOBLAST LTD For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast GAAP EPS of -$0.025 beats by $0.13, revenue of $1.94M misses by $0.18M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023

NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

Form 6-K MESOBLAST LTD For: Apr 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Appendix 4C Quarterly Activity Report

Mesoblast Financial and Operational Highlights for Quarter Ended March 31, 2023 Mesoblast Financial and Operational Highlights for Quarter Ended March…

XFRA : LWBA: Wiederaufnahme/Resumption

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE. THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING…

Why A2 Milk, Mesoblast, Mineral Resources, and Synlait shares are sinking

These ASX shares are likely to wish that the market had stayed closed for another day. The post Why A2 Milk,…

Why did the Mesoblast share price just dive 12%?

The medicines developer has completed a US$40 million private capital raising at 85 cents per share. The post Why did…

Mesoblast Completes Private Placement

NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

XFRA : LWBA: Aussetzung/Suspension

DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT: THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT: INSTRUMENT NAME …

William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication

Latest Ratings for MESO DateFirmActionFromTo Aug 2021Chardan CapitalMaintainsSell Apr 2021Maxim GroupUpgradesHoldBuy Jan 2021JefferiesDowngradesBuyHold View More…

ADRs End Higher, Mesoblast, Gol Linhas Aereas Inteligentes Trade Actively

ADRs End Higher, Mesoblast, Gol Linhas Aereas Inteligentes Trade Actively...…

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission >MESO

Mesoblast ADSs Rally as FDA Accepts Remestemcel-L Resubmission >MESO...…

Form 6-K MESOBLAST LTD For: Mar 08

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast stock surges ~10% on getting FDA review of graft versus host disease therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff. The post Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano…

Mesoblast share price rockets 23% on FDA news

Mesoblast has received some good news for the US FDA this morning. The post Mesoblast share price rockets 23% on FDA…

Form 6-K MESOBLAST LTD For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why De Grey, Kogan, Mayne Pharma, and Mesoblast shares are charging higher

These ASX shares are having a strong session on Tuesday... The post Why De Grey, Kogan, Mayne Pharma, and Mesoblast shares…

Mesoblast (ASX:MSB) flags strengthened heart function in latest trial results

Mesoblast (MSB) has reported results from a recent phase III trial showing…...…

Mesoblast Reports Operational and Financial Highlights for Quarter Ended December 31, 2022

NEW YORK, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of the American College of Cardiology (JACC)

Single Intra-Myocardial Intervention with Rexlemestrocel-L Reduced Cardiovascular Death, Myocardial Infarction or Stroke Over Mean Follow-Up of 30 Months in High-Risk Patients…

Mesoblast Financial Results and Corporate Update Webcast

NEW YORK, Feb. 26, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

Mesoblast share price soars 11% on FDA update

This healthcare share has started 2023 in sensational form and is now up 50% year to date... The post Mesoblast share…

FDA Grants Regenerative Medicine Advanced Therapy (Rmat) Designation for Rexlemestrocel-L in Chronic Low Back Pain

NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines…

Form 6-K MESOBLAST LTD For: Feb 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application

Mesoblast Shares Rise 11% After Resubmitting Biologics License Application...…

Why Argosy Minerals, Credit Corp, Flight Centre, and Mesoblast shares are racing higher

These ASX shares are outperforming the market on Wednesday.. The post Why Argosy Minerals, Credit Corp, Flight Centre, and Mesoblast shares…

Mesoblast Resubmits Biologic License Application (BLA) to FDA for Remestemcel-L in Children With Steroid-Refractory Acute Graft Versus Host Disease (Sr-aGVHD)

Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measures In-Vivo Activity based on Mechanism of Action...…

Appendix 4C Quarterly Activity Report

Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2022 Mesoblast Operational and Financial Highlights for Quarter Ended December…